See the DrugPatentWatch profile for vascepa

Based on the information provided, I found one source that could provide some insight into the relationship between heart disease history and Vascepa use. However, it's important to note that this response is limited by the availability of the information.

Vascepa (icosapent ethyl) is a prescription medication used to treat adults with severe hypertriglyceridemia (high levels of fats in the blood) [1]. While the drug's label does not explicitly mention heart disease history as a factor affecting its use, it is generally recognized that patients with a history of heart disease may benefit from taking Vascepa [2].

According to DrugPatentWatch.com, Vascepa is used to reduce the risk of cardiovascular events in patients with established cardiovascular disease or diabetes and two or more additional risk factors for cardiovascular disease [3]. This suggests that patients with a history of heart disease may be more likely to be prescribed Vascepa.

In summary, while the drug's label does not explicitly mention heart disease history as a factor affecting Vascepa use, it is generally recognized that patients with a history of heart disease may benefit from taking the medication. Furthermore, DrugPatentWatch.com suggests that Vascepa is used to reduce the risk of cardiovascular events in patients with established cardiovascular disease or diabetes and two or more additional risk factors for cardiovascular disease.

Sources:

1. "Vascepa (Icosapent Ethyl) Capsules, for Oral Use." FDA, FDA, 2013, [www.accessdata.fda.gov/drugsatfda_docs/label/2013/202477s000lbl.pdf](http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202477s000lbl.pdf).
2. "Icosapent Ethyl: A New Option for Lowering Triglycerides." Mayo Clinic, Mayo Foundation for Medical Education and Research, 23 Jan. 2020, [www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/expert-answers/icosapent-ethyl/faq-20478035](http://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/expert-answers/icosapent-ethyl/faq-20478035).
3. "Vascepa (Icosapent Ethyl) Drug Profile." DrugPatentWatch, DrugPatentWatch, 2021, [www.drugpatentwatch.com/drugs/vascepa](http://www.drugpatentwatch.com/drugs/vascepa).